Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy-Reference-Cited by-同舟云学术

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy

Published:2013-02-15 Issue:4 Volume:70 Page:343-349
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Uchida Mayako¹,Ikesue Hiroaki¹,Kato Koji²,Ichinose Kimiko³,Hiraiwa Hiromi³,Sakurai Asako³,Takenaka Katsuto⁴,Iwasaki Hiromi⁴,Miyamoto Toshihiro⁴,Teshima Takanori⁵,Egashira Nobuaki⁶,Akashi Koichi⁷,Oishi Ryozo⁶¹

Affiliation:

1. Department of Pharmacy, Kyushu University Hospital (KUH), Fukuoka, Japan

2. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka

3. Unit for Cell Therapy and Transplantation, KUH

4. Department of Medicine and Biosystemic Science

5. Center for Cellular and Molecular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka

6. Department of Pharmacy, KUH

7. Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/70/4/343/28456695/ajhp0343.pdf

Reference38 articles.

1. Chemotherapy-induced nausea and vomiting;Hesketh;N Engl J Med,2008

2. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010

3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Antiemesis. V. 1.2012. www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf (accessed 2012 May 16).

4. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement;Einhorn;Support Care Cancer,2011

5. Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy;Handberg;Support Care Cancer,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiemetic prophylaxis for induction chemotherapy in patients with acute myeloid leukemia;Journal of Oncology Pharmacy Practice;2020-04-19

2. Effect of aprepitant on concentration of tacrolimus induced by pretreatment for hematopoietic stem cell transplantation;Journal of Hematopoietic Cell Transplantation;2020

3. Clinical Pharmacology Research for Promoting Individualized Cancer Chemotherapy;YAKUGAKU ZASSHI;2019-06-01

4. Current and future treatment management strategies for gastroparesis;Expert Opinion on Orphan Drugs;2019-05-04

5. Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel;Cancer Chemotherapy and Pharmacology;2019-01-24